These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 20145128)
1. Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Ward CS; Venkatesh HS; Chaumeil MM; Brandes AH; Vancriekinge M; Dafni H; Sukumar S; Nelson SJ; Vigneron DB; Kurhanewicz J; James CD; Haas-Kogan DA; Ronen SM Cancer Res; 2010 Feb; 70(4):1296-305. PubMed ID: 20145128 [TBL] [Abstract][Full Text] [Related]
2. Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma. Venkatesh HS; Chaumeil MM; Ward CS; Haas-Kogan DA; James CD; Ronen SM Neuro Oncol; 2012 Mar; 14(3):315-25. PubMed ID: 22156546 [TBL] [Abstract][Full Text] [Related]
3. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Chaumeil MM; Ozawa T; Park I; Scott K; James CD; Nelson SJ; Ronen SM Neuroimage; 2012 Jan; 59(1):193-201. PubMed ID: 21807103 [TBL] [Abstract][Full Text] [Related]
4. Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring. Chaumeil MM; Radoul M; Najac C; Eriksson P; Viswanath P; Blough MD; Chesnelong C; Luchman HA; Cairncross JG; Ronen SM Neuroimage Clin; 2016; 12():180-9. PubMed ID: 27437179 [TBL] [Abstract][Full Text] [Related]
5. MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival. Radoul M; Chaumeil MM; Eriksson P; Wang AS; Phillips JJ; Ronen SM Mol Cancer Ther; 2016 May; 15(5):1113-22. PubMed ID: 26883274 [TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer. Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023 [TBL] [Abstract][Full Text] [Related]
7. Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells. Su JS; Woods SM; Ronen SM NMR Biomed; 2012 Feb; 25(2):379-88. PubMed ID: 22253088 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of LDH-A and glutaminase inhibition in vivo by hyperpolarized 13C-pyruvate magnetic resonance spectroscopy of tumors. Dutta P; Le A; Vander Jagt DL; Tsukamoto T; Martinez GV; Dang CV; Gillies RJ Cancer Res; 2013 Jul; 73(14):4190-5. PubMed ID: 23722553 [TBL] [Abstract][Full Text] [Related]
9. Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells. Beloueche-Babari M; Jackson LE; Al-Saffar NM; Eccles SA; Raynaud FI; Workman P; Leach MO; Ronen SM Mol Cancer Ther; 2006 Jan; 5(1):187-96. PubMed ID: 16432178 [TBL] [Abstract][Full Text] [Related]
10. Dual inhibition of PI3K and mTOR signaling pathways decreases human pancreatic neuroendocrine tumor metastatic progression. Djukom C; Porro LJ; Mrazek A; Townsend CM; Hellmich MR; Chao C Pancreas; 2014 Jan; 43(1):88-92. PubMed ID: 24263107 [TBL] [Abstract][Full Text] [Related]
11. HDAC inhibition in glioblastoma monitored by hyperpolarized Radoul M; Najac C; Viswanath P; Mukherjee J; Kelly M; Gillespie AM; Chaumeil MM; Eriksson P; Delos Santos R; Pieper RO; Ronen SM NMR Biomed; 2019 Feb; 32(2):e4044. PubMed ID: 30561869 [TBL] [Abstract][Full Text] [Related]
12. Hyperpolarized [1- Rao Y; Gammon S; Zacharias NM; Liu T; Salzillo T; Xi Y; Wang J; Bhattacharya P; Piwnica-Worms D Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22378-22389. PubMed ID: 32839325 [TBL] [Abstract][Full Text] [Related]
13. Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma. Minami N; Hong D; Stevers N; Barger CJ; Radoul M; Hong C; Chen L; Kim Y; Batsios G; Gillespie AM; Pieper RO; Costello JF; Viswanath P; Ronen SM Neuro Oncol; 2022 Nov; 24(11):1898-1910. PubMed ID: 35460557 [TBL] [Abstract][Full Text] [Related]
14. Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells. Sunayama J; Sato A; Matsuda K; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C Neuro Oncol; 2010 Dec; 12(12):1205-19. PubMed ID: 20861085 [TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo. Liu Y; Cui B; Qiao Y; Zhang Y; Tian Y; Jiang J; Ma D; Kong B Int J Gynecol Cancer; 2011 Jan; 21(1):100-5. PubMed ID: 21330835 [TBL] [Abstract][Full Text] [Related]
16. Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI. Mignion L; Dutta P; Martinez GV; Foroutan P; Gillies RJ; Jordan BF Cancer Res; 2014 Feb; 74(3):686-94. PubMed ID: 24285723 [TBL] [Abstract][Full Text] [Related]
17. Offset of apparent hyperpolarized Choi YS; Lee J; Lee HS; Song JE; Kim DH; Song HT NMR Biomed; 2021 Aug; 34(8):e4561. PubMed ID: 34080736 [TBL] [Abstract][Full Text] [Related]
18. Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells. Fujiwara M; Izuishi K; Sano T; Hossain MA; Kimura S; Masaki T; Suzuki Y J Exp Clin Cancer Res; 2008 Nov; 27(1):76. PubMed ID: 19032736 [TBL] [Abstract][Full Text] [Related]
19. A Metabolomics Study of Hypoxia Ischemia during Mouse Brain Development Using Hyperpolarized 13C. Mikrogeorgiou A; Chen Y; Lee BS; Bok R; Sheldon RA; Barkovich AJ; Xu D; Ferriero DM Dev Neurosci; 2020; 42(1):49-58. PubMed ID: 32570236 [TBL] [Abstract][Full Text] [Related]